A radiolabeled antibody targeting CD123+ leukemia stem cells – initial radioimmunotherapy studies in NOD/SCID mice engrafted with primary human AML
Radioimmunotherapy (RIT) with anti-CD123 monoclonal antibody CSL360 modified with nuclear translocation sequence (NLS) peptides and labeled with the Auger electron-emitter, 111In (111In-NLS-CSL360) was studied in the prevalent NOD/SCID mouse AML engraftment assay. Significant decreases in CD123+ leu...
Main Authors: | Jeffrey V. Leyton, Catherine Gao, Brent Williams, Armand Keating, Mark Minden, Raymond M. Reilly |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-01-01
|
Series: | Leukemia Research Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213048915300121 |
Similar Items
-
Formulation of a kit under Good Manufacturing Practices (GMP) for preparing [111In]In-BnDTPA-trastuzumab-NLS injection: a theranostic agent for imaging and Meitner-Auger Electron (MAE) radioimmunotherapy of HER2-positive breast cancer
by: Conrad Chan, et al.
Published: (2022-12-01) -
Spiny mice (Acomys) cells fail to engraft in NOD scid gamma.
by: Janak Gaire, et al.
Published: (2023-01-01) -
Radioimmunotherapy of lymphoma
by: Goldsmith Stanley J.
Published: (2012-01-01) -
Genetic labelling of human bone marrow osteogenic stem cells: Differentiation potentials and engraftment into NOD/SCID mice.
by: Xia, Z, et al.
Published: (2001) -
Molecular Imaging and Preclinical Studies of Radiolabeled Long-Term RGD Peptides in U-87 MG Tumor-Bearing Mice
by: Wei-Lin Lo, et al.
Published: (2021-05-01)